IMPEKLO Drug Patent Profile
✉ Email this page to a colleague
When do Impeklo patents expire, and what generic alternatives are available?
Impeklo is a drug marketed by Mylan and is included in one NDA.
The generic ingredient in IMPEKLO is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Impeklo
A generic version of IMPEKLO was approved as clobetasol propionate by COSETTE on February 16th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IMPEKLO?
- What are the global sales for IMPEKLO?
- What is Average Wholesale Price for IMPEKLO?
Summary for IMPEKLO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Patent Applications: | 4,356 |
| Drug Prices: | Drug price information for IMPEKLO |
| What excipients (inactive ingredients) are in IMPEKLO? | IMPEKLO excipients list |
| DailyMed Link: | IMPEKLO at DailyMed |
US Patents and Regulatory Information for IMPEKLO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan | IMPEKLO | clobetasol propionate | LOTION;TOPICAL | 213691-001 | May 19, 2020 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
